(Q57241733)

2

0 references

Anne Motte

3

0 references

Mireille Henry

4

0 references

Valérie Moal

5

0 references

Danielle Botta-Fridlund

6

0 references

Catherine Tamalet

7

0 references

René Gérolami

The clinical significance of surface antigen variants of hepatitis B virus

8

0 references

language of work or name

English

0 references

publication date

October 2007

0 references

published in

Virology

0 references

volume

367

0 references

issue

1

0 references

page(s)

30-40

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.05.012

Vaccine-induced escape mutant of hepatitis B virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.05.012

Vaccine- and hepatitis B immune globulin-induced escape mutations of hepatitis B virus surface antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.05.012

Concomitant hepatitis B surface antigen and antibody in thirteen patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.05.012

Frequency of concurrence of hepatitis B surface antigen and antibody in a large number of carriers in Okinawa, Japan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.05.012

Co-occurrence of HBsAg and anti-HBs: Two consecutive infections or a sign of advanced chronic liver disease?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.05.012

Changes of hepatitis B surface antigen variants in carrier children before and after universal vaccination in taiwan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.05.012

Characterization of a novel hepatitis B virus mutant: demonstration of mutation-induced hepatitis B virus surface antigen group specific "a" determinant conformation change and its application in diagnostic assays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.05.012

Mutations in the envelope gene of hepatitis B virus variants co-occurring with antibody to surface antigen in sera from patients with chronic hepatitis B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.05.012

Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.05.012

Coexistence of hepatitis B surface antigen (HBs Ag) and anti-HBs antibodies in chronic hepatitis B virus carriers: influence of "a" determinant variants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.05.012

Emergence of vaccine-induced escape mutant of hepatitis B virus with multiple surface gene mutations in a Korean child

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.05.012

A single amino acid in the reverse transcriptase domain of hepatitis B virus affects virus replication efficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.05.012

De Novo Infection in a Renal Transplant Recipient Caused by Novel Mutants of Hepatitis B Virus Despite the Presence of Protective Anti–Hepatitis B Surface Antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.05.012

Sensitivities of four new commercial hepatitis B virus surface antigen (HBsAg) assays in detection of HBsAg mutant forms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.05.012

A quasi-monoclonal anti-HBs response can lead to immune escape of 'wild-type' hepatitis B virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.05.012

The concept of hepatitis B virus mutant escape

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.05.012

Clinical practice: prevention of hepatitis B with the hepatitis B vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.05.012

Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.05.012

Mutations affecting the replication capacity of the hepatitis B virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.05.012

Frequency and significance of concurrent hepatitis B surface antigen and antibody in acute and chronic hepatitis B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.05.012

Restoration of replication phenotype of lamivudine-resistant hepatitis B virus mutants by compensatory changes in the "fingers" subdomain of the viral polymerase selected as a consequence of mutations in the overlapping S gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.05.012

Reduced antigenicity of the hepatitis B virus HBsAg protein arising as a consequence of sequence changes in the overlapping polymerase gene that are selected by lamivudine therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.05.012

Clinical significance of concurrent hepatitis B surface antigen and antibody positivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.05.012

Detection of pre-S/S gene mutants in chronic hepatitis B carriers with concurrent hepatitis B surface antibody and hepatitis B surface antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.05.012

Genetic variability of the S gene of hepatitis B virus: clinical and diagnostic impact

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.05.012

A novel deletion mutant of hepatitis B virus surface antigen.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.05.012

High genetic variability of the group-specific a-determinant of hepatitis B virus surface antigen (HBsAg) and the corresponding fragment of the viral polymerase in chronic virus carriers lacking detectable HBsAg in serum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.05.012

Evolution of multi-drug resistant hepatitis B virus during sequential therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.05.012

Mutant hepatitis B virus surface antigens (HBsAg) are immunogenic but may have a changed specificity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.05.012

Mutations of the surface protein of hepatitis B virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.05.012